Merck Meets Endpoints
Merck's Tulisokibart met primary and secondary endpoints
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
MRK Meets Endpoints
Merck's Tulisokibart meets primary and key secondary endpoints in Phase 3 ATLAS-UC induction-only study for ulcerative colitis